Image source: © 2025 Krish Capital Pty.Ltd

Highlights

  • Received USD 3.6m non-dilutive funding; USD 25m reimbursements remain over two years.
  • Selected for ALTA program; IEA cites company among notable LFP innovators.
  • Began OTCQB trading to improve U.S. market access and visibility.

Nano One Materials Corp. (OTCQB: NNOMF) reported Q2 2025 results reflecting a mix of balance-sheet resilience and continued investment in technology development. The company ended the quarter with total net assets of USD 23.2 million and working capital of USD 22.8 million, while posting a net loss of USD 2.8 million. During the period, Nano One secured USD 3.6 million in non-dilutive government funding to support ongoing programs. Management also noted a sequential decrease in total assets of USD 2.6 million from Q1 to Q2 2025, consistent with operating spend and project timing.

Operationally, Nano One advanced several strategic initiatives aimed at strengthening its position within the lithium iron phosphate (LFP) battery materials ecosystem. The company was selected for the Arkansas Lithium Technology Accelerator (ALTA) program, a collaboration intended to accelerate commercialization pathways and regional supply chain development in the United States. In parallel, the International Energy Agency recognized Nano One among leading innovators in LFP technology, reflecting continued attention on process improvements and cost-efficiency in cathode materials manufacturing.

To broaden investor access, Nano One commenced trading on the U.S. OTCQB market during the quarter. The listing is intended to facilitate engagement with U.S. investors and enhance secondary market liquidity without immediate changes to capital structure. Looking ahead, the company reports approximately USD 25.0 million of remaining government program reimbursements available to claim over the next two years, providing a potential source of non-dilutive funding for development milestones and scale-up activities.

From a financial perspective, the quarter’s net loss underscores the profile of a company still in the development and commercialization phase, where expenditures on R&D, pilot operations, and partnerships can outpace near-term revenue streams. The combination of working capital of USD 22.8 million and expected reimbursements offers flexibility to continue executing near-term objectives, though disciplined cost management and milestone pacing remain important given the asset decline versus Q1.

Key focus areas for the second half of 2025 include leveraging ALTA resources, advancing LFP process demonstrations with partners, and timing grant reimbursements to support cash planning. Investors will monitor progress on commercialization agreements, unit economics at scale, and any updates to funding sources. Overall, Q2 2025 highlights incremental external validation and funding access, balanced against operating losses and a competitive cathode materials landscape.